Cargando…
Recent Progress of Potentiating Immune Checkpoint Blockade with External Stimuli—an Industry Perspective
The past decade has seen the materialization of immune checkpoint blockade as an emerging approach to cancer treatment. However, the overall response and patient survival are still modest. Various efforts to study the “cancer immunogram” have highlighted complex biology that necessitates a multipron...
Autores principales: | Xu, Jun, Saklatvala, Robert, Mittal, Sachin, Deshmukh, Smeet, Procopio, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175294/ https://www.ncbi.nlm.nih.gov/pubmed/32328428 http://dx.doi.org/10.1002/advs.201903394 |
Ejemplares similares
-
Perspective: cancer vaccines in the era of immune checkpoint blockade
por: Cebon, Jonathan
Publicado: (2018) -
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
por: Lei, Yanna, et al.
Publicado: (2021) -
Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
por: Zhang, Na, et al.
Publicado: (2020) -
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
por: Chu, Pei-Yi, et al.
Publicado: (2021) -
Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
por: Ho, Rachel L. Y., et al.
Publicado: (2021)